Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Philip

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of carboplatin and paclitaxel in esophageal cancerB F El-Rayes, A Shields, M Zalupski, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
British Journal of Cancer|February 1, 1992
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideP A Philip, S Joel, S C Monkman, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.
Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.
Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancerB F El-Rayes, M M Zalupski, A F Shields, et al.
Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of carboplatin and paclitaxel in esophageal cancerB F El-Rayes, A Shields, M Zalupski, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
British Journal of Cancer|February 1, 1992
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideP A Philip, S Joel, S C Monkman, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.
Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.
Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancerB F El-Rayes, M M Zalupski, A F Shields, et al.
Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.
Pageof 7